Accelerate your Timelines in Neuroscience & Metabolic Clinical Development
Partner with a Clinical Research Organization (CRO) that specializes in managing the complexities of Neuroscience and Metabolic clinical development programs. Better Science. Superior Results.
Supporting clinical research across all phases of drug development.
With science always guiding us, Lotus Clinical Research is an extension of your team, providing the expertise and insights to move your studies forward. We have unparalleled access to patients across the neuroscience and metabolic disease spectrum through our affiliation with Evolution Research Group (ERG), including state-of-the-art Phase 1 facilities. Specializing in obesity, diabetes, MASH, endocrinology, renal and hepatic impairment, pain, sleep, psychiatry, and addiction, our comprehensive clinical development services and in-house experts can help streamline and fast-track your next clinical study.
Speed AND Quality:
Access the ERG Site Network
Lotus is differentiated from other CROs by our common ownership with ERG. Our highly sought-after, US-based sites include 20 wholly-owned research units, over 400 beds, nine surgical centers, and multiple Phase 1 units, providing access to specialized capabilities for both healthy volunteer studies and targeted patient populations in neuroscience and metabolic disease research.
This unique Lotus-ERG structure enables rapid study startup and unparalleled operational efficiency, as many of the slow-track activities associated with site initiation (contracting, legal, etc.) are already in place. The leadership, medical, and operational teams are in constant communication and Lotus-Sponsor studies are prioritized.
Expect dramatically faster site start-up and patient recruitment with the Lotus-ERG advantage.
A Deeper Dive into Neuroscience Experience
Lotus has deep experience across the neuroscience disease spectrum, supporting all phases of development for novel medicines. We provide scientific leadership and have extensive experience with the neuroscience approval process.
Neuroscience Drug Approvals
Neuroscience Studies Completed
Number FDA Inspections Resulting in a 483
Note: Statistics combine experience from both Lotus Clinical Research and Evolution Research Group’s network of clinical research sites.
A Deeper Dive into Metabolic Experience
ERG’s site network provides rapid access to some of the most well-respected sites in the country for metabolic research in diabetes, MASH, and obesity. Guided by a science-first approach, our Scientific Leadership Team brings extensive experience in obesity and metabolic research.
Studies Conducted
Metabolic Studies Conducted
Obesity Studies Conducted
Note: Statistics combine experience from both Lotus Clinical Research and Evolution Research Group’s network of clinical research sites.
